Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Tangible Net Worth Ratio
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Tangible Net Worth Ratio of 89.9% as of September 2025. This metric is calculated by deducting intangible assets (CN¥115.68 Million) from net assets (CN¥1.15 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Shaanxi Meibang Pharmaceutical Group Co to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shaanxi Meibang Pharmaceutical Group Co Ltd Tangible Net Worth Ratio (2017–2024)
This chart shows how Shaanxi Meibang Pharmaceutical Group Co Ltd's Tangible Net Worth Ratio has changed across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 89.9%, reflecting net assets of CN¥1.15 Billion with intangible assets of CN¥115.68 Million CNY. See 605033 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 605033 stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.5% | CN¥1.12 Billion | CN¥118.48 Million | CN¥1.86 Billion | ▼ -3.1 pp |
| 2023 | 92.5% | CN¥1.11 Billion | CN¥83.23 Million | CN¥1.69 Billion | ▼ -6.3 pp |
| 2022 | 98.9% | CN¥1.09 Billion | CN¥12.27 Million | CN¥1.56 Billion | ▼ -0.3 pp |
| 2021 | 99.2% | CN¥966.95 Million | CN¥7.70 Million | CN¥1.46 Billion | ▲ +1.0 pp |
| 2020 | 98.2% | CN¥449.37 Million | CN¥7.94 Million | CN¥785.87 Million | ▲ +0.5 pp |
| 2019 | 97.8% | CN¥370.63 Million | CN¥8.27 Million | CN¥665.97 Million | ▲ +0.9 pp |
| 2018 | 96.9% | CN¥276.37 Million | CN¥8.70 Million | CN¥585.78 Million | ▲ +0.6 pp |
| 2017 | 96.2% | CN¥180.43 Million | CN¥6.81 Million | CN¥509.66 Million | — |